Back to Search
Start Over
SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues.
- Source :
-
Leukemia research [Leuk Res] 2021 Aug; Vol. 107, pp. 106608. Date of Electronic Publication: 2021 May 03. - Publication Year :
- 2021
- Subjects :
- Antineoplastic Agents pharmacology
Humans
Lymphoma, Mantle-Cell drug therapy
Nucleosides analogs & derivatives
Nucleosides pharmacology
Recurrence
Drug Resistance, Neoplasm genetics
Lymphoma, Mantle-Cell genetics
Lymphoma, Mantle-Cell pathology
Mutation
SAM Domain and HD Domain-Containing Protein 1 genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1873-5835
- Volume :
- 107
- Database :
- MEDLINE
- Journal :
- Leukemia research
- Publication Type :
- Report
- Accession number :
- 33979727
- Full Text :
- https://doi.org/10.1016/j.leukres.2021.106608